Search - tctmd.com

Displaying 1 - 20 of 85

Sort: Relevancy | Date

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

News Conference News PCR London Valves 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Conference News PCR London Valves 2019

Two Small Series Support Role for Cerebral Protection in TAVR

Michael O'Riordan

November 18, 2019

News Conference News PCR London Valves 2019

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Michael O'Riordan

November 17, 2019

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

Presentation TCT Abstracts Posters 2019

Manual Hemostasis of Percutaneous Axillary Artery Access Following Intra-Aortic Balloon Pump (IABP) Insertion

Presenter: Michael DiVita

October 09, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Presenter: Michael Mack

September 28, 2019

News Conference News TCT 2019

Surgical Volume Matters When It Comes to Repair of Primary MR

Todd Neale

September 28, 2019

Presentation TCT 2019

Focus FMR: Trial Data, Patient Selection, and Synergistic Therapies

Presenter: Michael Mack

September 28, 2019

Advertisement

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Two Small Series Support Role for Cerebral Protection in TAVR

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Manual Hemostasis of Percutaneous Axillary Artery Access Following Intra-Aortic Balloon Pump (IABP) Insertion

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Surgical Volume Matters When It Comes to Repair of Primary MR

Focus FMR: Trial Data, Patient Selection, and Synergistic Therapies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content